The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T1-Weighted Magnetic Resonance Imaging and Chemotherapy
Abstract
The recently emerged exceedingly small magnetic iron oxide nanoparticles (ES-MIONs) (<5 nm) are promising T 1 -weighted contrast agents for magnetic resonance imaging (MRI) due to their good biocompatibility compared with Gd-chelates. However, the best particle size of ES-MIONs for T 1 imaging is still unknown because the synthesis of ES-MIONs with precise size control to clarify the relationship between the r 1 (or r 2 / r 1 ) and the particle size remains a challenge. In this study, we synthesized ES-MIONs with seven different sizes below 5 nm and found that 3.6 nm is the best particle size for ES-MIONs to be utilized as T 1 -weighted MR contrast agent. To enhance tumor targetability of theranostic nanoparticles and reduce the nonspecific uptake of nanoparticles by normal healthy cells, we constructed a drug delivery system based on the 3.6 nm ES-MIONs for T 1 -weighted tumor imaging and chemotherapy. The laser scanning confocal microscopy (LSCM) and flow cytometry analysis results demonstrate that our strategy of precise targeting via exposure or hiding of the targeting ligand RGD 2 on demand is feasible. The MR imaging and chemotherapy results on the cancer cells and tumor-bearing mice reinforce that our DOX@ES-MION3@RGD 2 @mPEG3 nanoparticles are promising for high-resolution T 1 -weighted MR imaging and precise chemotherapy of tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Inorganic Nanoparticles for MRI Contrast Agents
Na, H. B., Song, I. C., & Hyeon, T. (2009) · Advanced Materials · doi:10.1002/adma.200802366 · Cited by 1,781
Liu, J., Sun, Z., Deng, Y., Zou, Y., Li, C., Guo, X., Xiong, L., Gao, Y., Li, F., & Zhao, D. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901566 · Cited by 1,057
Kim, B. H., Lee, N., Kim, H., An, K., Park, Y. I., Choi, Y., Shin, K., Lee, Y., Kwon, S. G., Na, H. B., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203340u · Cited by 947
Yang, K., Hu, L., Ma, X., Ye, S., Cheng, L., Shi, X., Li, C., Li, Y., & Liu, Z. (2012) · Advanced Materials · doi:10.1002/adma.201104964 · Cited by 943
Self-citationMultifunctional magnetic nanoparticles for targeted imaging and therapy
MCCARTHY, J., & WEISSLEDER, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.014 · Cited by 892
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
Wei, H., Bruns, O. T., Kaul, M. G., Hansen, E. C., Barch, M., Wiśniowska, A., Chen, O., Chen, Y., Li, N., Okada, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620145114 · Cited by 489
Unni, M., Uhl, A. M., Savliwala, S., Savitzky, B. H., Dhavalikar, R., Garraud, N., Arnold, D. P., Kourkoutis, L. F., Andrew, J. S., & Rinaldi, C. (2017) · ACS Nano · doi:10.1021/acsnano.7b00609 · Cited by 411
Tromsdorf, U. I., Bruns, O. T., Salmen, S. C., Beisiegel, U., & Weller, H. (2009) · Nano Letters · doi:10.1021/nl902715v · Cited by 396
Mikhaylov, G., Mikac, U., Magaeva, A. A., Itin, V. I., Naiden, E. P., Psakhye, I., Babes, L., Reinheckel, T., Peters, C., Zeiser, R., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.112 · Cited by 383
Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging
Shen, Z., Wu, A., & Chen, X. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00839 · Cited by 328
Self-citationLiu, F., He, X., Chen, H., Zhang, J., Zhang, H., & Wang, Z. (2015) · Nature Communications · doi:10.1038/ncomms9003 · Cited by 295
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
Chen, H., Niu, G., Wu, H., & Chen, X. (2016) · Theranostics · doi:10.7150/thno.13242 · Cited by 282
Self-citationEngineered Iron-Oxide-Based Nanoparticles as Enhanced T1 Contrast Agents for Efficient Tumor Imaging
Zhou, Z., Wang, L., Chi, X., Bao, J., Yang, L., Zhao, W., Chen, Z., Wang, X., Chen, X., & Gao, J. (2013) · ACS Nano · doi:10.1021/nn305991e · Cited by 249
Self-citationWang, Y., & Gu, H. (2015) · Advanced Materials · doi:10.1002/adma.201401124 · Cited by 247
Zhang, H., Li, L., Liu, X. L., Jiao, J., Ng, C.-T., Yi, J. B., Luo, Y. E., Bay, B.-H., Zhao, L. Y., Peng, M. L., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b07684 · Cited by 224
Magnetic resonance imaging contrast agents: Overview and perspectives
Yan, G.-P., Robinson, L., & Hogg, P. (2007) · Radiography · doi:10.1016/j.radi.2006.07.005 · Cited by 212
Basic MR relaxation mechanisms and contrast agent design
De León‐Rodríguez, L. M., Martins, A. F., Pinho, M. C., Rofsky, N. M., & Sherry, A. D. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24787 · Cited by 211
In Vivo Clearance and Toxicity of Monodisperse Iron Oxide Nanocrystals
Gu, L., Fang, R. H., Sailor, M. J., & Park, J.-H. (2012) · ACS Nano · doi:10.1021/nn300456z · Cited by 209
Li, Z., Yi, P. W., Sun, Q., Lei, H., Li Zhao, H., Zhu, Z. H., Smith, S. C., Lan, M. B., & Lu, G. Q. (. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201103123 · Cited by 209
Self-citationSmall is Smarter: Nano MRI Contrast Agents – Advantages and Recent Achievements
Gao, Z., Ma, T., Zhao, E., Docter, D., Yang, W., Stauber, R. H., & Gao, M. (2016) · Small · doi:10.1002/smll.201502309 · Cited by 195
Koning, G. A., Schiffelers, R. M., Wauben, M. H. M., Kok, R. J., Mastrobattista, E., Molema, G., ten Hagen, T. L. M., & Storm, G. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21719 · Cited by 185
Paramagnetic fluorinated nanoemulsions for sensitive cellular fluorine-19 magnetic resonance imaging
Kislukhin, A. A., Xu, H., Adams, S. R., Narsinh, K. H., Tsien, R. Y., & Ahrens, E. T. (2016) · Nature Materials · doi:10.1038/nmat4585 · Cited by 179
Park, S.-H., Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Kim, D.-Y., Szardenings, M., Min, J. H., Hong, Y., Choy, H. E., & Min, J.-J. (2016) · Theranostics · doi:10.7150/thno.16135 · Cited by 176
Zhou, Z., Zhao, Z., Zhang, H., Wang, Z., Chen, X., Wang, R., Chen, Z., & Gao, J. (2014) · ACS Nano · doi:10.1021/nn5038652 · Cited by 175
Self-citationSimple Synthesis and Functionalization of Iron Nanoparticles for Magnetic Resonance Imaging
Cheong, S., Ferguson, P., Feindel, K. W., Hermans, I. F., Callaghan, P. T., Meyer, C., Slocombe, A., Su, C., Cheng, F., Yeh, C., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100562 · Cited by 171
Pinho, S. L. C., Pereira, G. A. L., Voisin, P. J., Kassem, J., Bouchaud, V., Etienne, L., Peters, J. A., Carlos, L. D., Mornet, S., Geraldes, C. F. G. C., et al. (2010) · ACS Nano · doi:10.1021/nn101129r · Cited by 156
Kucheryavy, P., He, J., John, V. T., Maharjan, P., Spînu, L., Goloverda, G. Z., & Kolesnichenko, V. L. (2012) · Langmuir · doi:10.1021/la3037007 · Cited by 156
Huang, G., Li, H., Chen, J., Zhao, Z., Yang, L., Chi, X., Chen, Z., Wang, X., & Gao, J. (2014) · Nanoscale · doi:10.1039/c4nr02680b · Cited by 150
Luo, Y., Yang, J., Yan, Y., Li, J., Shen, M., Zhang, G., Mignani, S. M., & Shi, X. (2015) · Nanoscale · doi:10.1039/c5nr04003e · Cited by 143
Park, J. Y., Patel, D., Lee, G. H., Woo, S., & Chang, Y. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/36/365603 · Cited by 143
Li, Z., Tan, B., Allix, M. M. B., Cooper, A. I., & Rosseinsky, M. J. (2008) · Small · doi:10.1002/smll.200700575 · Cited by 143
Self-citationZhou, Z., Wu, C., Liu, H., Zhu, X., Zhao, Z., Wang, L., Xu, Y., Ai, H., & Gao, J. (2015) · ACS Nano · doi:10.1021/nn507193f · Cited by 135
Self-citationWang, Y., Chen, J., Yang, B. Y., Qiao, H., Gao, L., Su, T., Ma, S., Zhang, X., Li, X., Liu, G., et al. (2015) · Theranostics · doi:10.7150/thno.13350 · Cited by 116
Self-citationEnvironment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching
Kaittanis, C., Shaffer, T. M., Ogirala, A., Santra, S., Perez, J. M., Chiosis, G., Li, Y., Josephson, L., & Grimm, J. (2014) · Nature Communications · doi:10.1038/ncomms4384 · Cited by 107
Huang, J., Wang, L., Zhong, X., Li, Y., Yang, L. P. H., & Mao, H. Z. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00811a · Cited by 76
Jia, Z., Song, L., Zang, F., Song, J., Zhang, W., Yan, C., Xie, J., Ma, Z.-L., Ma, M., Teng, G., et al. (2016) · Theranostics · doi:10.7150/thno.14280 · Cited by 69
Self-citationDan, K., Pan, R., & Ghosh, S. (2010) · Langmuir · doi:10.1021/la104445h · Cited by 66
Antiferromagnetic Iron Nanocolloids: A New Generation in Vivo T1 MRI Contrast Agent
Peng, Y., Liu, C., Chen, H., Chou, S., Tseng, W., Tseng, Y., Kang, C., Hsiao, J., & Chou, P. (2013) · Journal of the American Chemical Society · doi:10.1021/ja409490q · Cited by 60
Shen, Z., Wu, H., Yang, S., Ma, X., Li, Z., Tan, M., & Wu, A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.022 · Cited by 56
Self-citationMelemenidis, S., Jefferson, A., Ruparelia, N., Akhtar, A. M., Xie, J., Allen, P. D., Hamilton, A., Larkin, J. R., Pérez-Balderas, F., Smart, S., et al. (2015) · Theranostics · doi:10.7150/thno.10319 · Cited by 56
Self-citationSynthesis of Carboxylated-Graphenes by the Kolbe–Schmitt Process
Eng, A. Y. S., Sofer, Z., Sedmidubský, D., & Pumera, M. (2017) · ACS Nano · doi:10.1021/acsnano.6b07746 · Cited by 51
Xia, Y., Wu, X., Zhao, J., Zhao, J., Li, Z., Ren, W., Tian, Y., Li, A., Shen, Z., & Wu, A. (2016) · Nanoscale · doi:10.1039/c6nr07172d · Cited by 45
Self-citationKang, T. W., Jeon, S., Kim, H., Park, J. H., Yim, D., Lee, H.-R., Ju, J., Kim, M.-J., & Kim, J. (2016) · ACS Nano · doi:10.1021/acsnano.6b01495 · Cited by 44
Shape-dependent cellular behaviors and relaxivity of iron oxide-based T 1 MRI contrast agents
Sherwood, J. A., Lovas, K., Rich, M. C., Yin, Q., Lackey, K., Bolding, M., & Bao, Y. (2016) · Nanoscale · doi:10.1039/c6nr06158c · Cited by 41
FMN-Coated Fluorescent USPIO for Cell Labeling and Non-Invasive MR Imaging in Tissue Engineering
Mertens, M. E., Frese, J., Bölükbas, D. A., Hrdlicka, L., Golombek, S. K., Koch, S., Mela, P., Jockenhoevel, S., Kiessling, F. M., & Lammers, T. (2014) · Theranostics · doi:10.7150/thno.8763 · Cited by 35
Phan, V. N., Lim, E., Kim, T., Kim, M., Choi, Y., Kim, B., Lee, M., Oh, A., Jin, J., Chae, Y., et al. (2013) · Advanced Materials · doi:10.1002/adma.201300525 · Cited by 34
Liu, C., Peng, Y., Chou, S., Tseng, W., Tseng, Y., Chen, H., Hsiao, J., & Chou, P. (2014) · Small · doi:10.1002/smll.201303868 · Cited by 34
Cited by
Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization
Sanità, G., Carrese, B., & Lamberti, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587012 · Cited by 765
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604
Self-citationStructure–Relaxivity Relationships of Magnetic Nanoparticles for Magnetic Resonance Imaging
Zhou, Z., Yang, L., Gao, J., & Chen, X. (2019) · Advanced Materials · doi:10.1002/adma.201804567 · Cited by 488
Self-citationJeon, M., Halbert, M. V., Stephen, Z. R., & Zhang, M. (2021) · Advanced Materials · doi:10.1002/adma.201906539 · Cited by 477
Versatile Types of Organic/Inorganic Nanohybrids: From Strategic Design to Biomedical Applications
Zhao, N., Yan, L., Zhao, X., Chen, X., Li, A., Zheng, D., Zhou, X., Dai, X., & Xu, F.-J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00401 · Cited by 429
Self-citation
Metadata
- Authors
- Shen, Z., Chen, T., Ma, X., Ren, W., Zhou, Z., Zhu, G., Zhang, A., Liu, Y., Song, J., Li, Z., Ruan, H., Fan, W., Lin, L., Munasinghe, J., Chen, X., & Wu, A.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-10-19
- Volume
- 11
- Issue
- 11
- Pages
- 10992-11004
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2765209067
- Cited by
- 298
- References
- 49
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.